微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 0.15% | -96.33% | 161.14% | 113/160 | 4.14% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | -0.24% | -111.32% | -146.77% | 115/160 | 2.6% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 0.52% | -64.14% | -76.99% | 105/160 | 2.3% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 2.26% | -16.61% | -44.2% | 86/160 | -0.96% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 4.05% | 3.58% | 88.47% | 81/160 | 2.37% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 2.15% | -6.97% | 48.2% | 83/160 | 1.51% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 1.45% | 12.4% | -46.49% | 73/160 | 1.38% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 2.71% | -52.54% | -30.69% | 91/160 | 0.8% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 3.91% | -53.45% | 69.26% | 74/160 | 2.89% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 2.31% | -60.45% | 79.07% | 81/160 | 2.24% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 1.29% | -61.14% | -77.41% | 80/160 | 1.61% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 5.71% | 220.97% | -32.02% | 76/160 | 0.94% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | 8.4% | 170.18% | 43.84% | 50/160 | 4.53% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 5.84% | 173.09% | 75.9% | 42/160 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 3.32% | 173.61% | 170.34% | 38/160 | 2.52% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | -4.72% | -244.34% | 60.57% | 116/160 | 3.74% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | -11.97% | -365.41% | -49.81% | 112/160 | 3.22% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | -7.99% | -456.7% | -77.16% | 123/160 | 4.24% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | -4.51% | -192.04% | -237.92% | 109/160 | 2.24% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 3.27% | 289.29% | -27.49% | 100/160 | 2.78% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 4.51% | 139.89% | 101.34% | 73/160 | 7.61% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 2.24% | 27.27% | -54.29% | 83/160 | 5.05% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 4.9% | 255.07% | 483.33% | 12/160 | 2.46% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 0.84% | -61.29% | -55.32% | 116/160 | 7.09% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 1.88% | 40.3% | 6.82% | 93/160 | 7.26% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 1.76% | 47.9% | 27.54% | 86/160 | 4.65% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 1.38% | 10.4% | -36.41% | 69/160 | 2.55% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 2.17% | 1305.56% | 61.94% | 107/160 | 9.66% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 1.34% | 10.74% | 12.61% | 91/160 | 8.31% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 1.19% | 26.6% | -4.8% | 91/160 | 5.59% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 1.25% | 104.92% | 794.44% | 59/160 | 2.1% | 河化股份 | 54.24% | 行业排名> |
| 2016-12-31 | -0.18% | -109.94% | -114.88% | 106/160 | 6.33% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 1.21% | 2.54% | 28.72% | 73/160 | 5.61% | 南新制药 | 81.7% | 行业排名> |
| 2016-06-30 | 0.94% | -39.74% | 54.1% | 77/160 | 3.53% | 德展健康 | 29.5% | 行业排名> |
| 2016-03-31 | 0.61% | -39.6% | -66.3% | 67/160 | 2.65% | 贝达药业 | 16.78% | 行业排名> |
| 2015-12-31 | 1.81% | 229.29% | 53.39% | 88/160 | 11.35% | 河化股份 | 19.29% | 行业排名> |
| 2015-09-30 | 1.18% | 227.78% | -24.36% | 65/160 | 7.22% | 一品红 | 58.17% | 行业排名> |
| 2015-06-30 | 1.56% | 200% | 54.46% | 60/160 | 4.9% | 华东医药 | 36.97% | 行业排名> |
| 2015-03-31 | 1.01% | 185.31% | 172.14% | 51/160 | 2.41% | 华东医药 | 26.63% | 行业排名> |